Annual CFI
$4.60 M
-$111.48 M-96.03%
31 December 2023
Summary:
Pacific Biosciences of California annual cash flow from investing activities is currently $4.60 million, with the most recent change of -$111.48 million (-96.03%) on 31 December 2023. During the last 3 years, it has risen by +$223.93 million (+102.10%). PACB annual CFI is now -96.03% below its all-time high of $116.08 million, reached on 31 December 2022.PACB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$23.07 M
-$53.77 M-69.98%
30 September 2024
Summary:
Pacific Biosciences of California quarterly cash flow from investing activities is currently $23.07 million, with the most recent change of -$53.77 million (-69.98%) on 30 September 2024. Over the past year, it has dropped by -$219.26 million (-90.48%). PACB quarterly CFI is now -90.48% below its all-time high of $242.32 million, reached on 30 September 2023.PACB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$809.00 K
-$219.26 M-100.37%
30 September 2024
Summary:
Pacific Biosciences of California TTM cash flow from investing activities is currently -$809.00 thousand, with the most recent change of -$219.26 million (-100.37%) on 30 September 2024. Over the past year, it has dropped by -$152.39 million (-100.53%). PACB TTM CFI is now -100.37% below its all-time high of $218.45 million, reached on 30 June 2024.PACB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.0% | -90.5% | -100.5% |
| 3 y3 years | +102.1% | +107.9% | +99.9% |
| 5 y5 years | +112.0% | +17.3% | -101.3% |
PACB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -96.0% | +100.7% | -90.5% | +107.9% | -100.4% | +99.9% |
| 5 y | 5 years | -96.0% | +100.7% | -90.5% | +105.0% | -100.4% | +99.9% |
| alltime | all time | -96.0% | +100.7% | -90.5% | +105.0% | -100.4% | +99.9% |
Pacific Biosciences Of California Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.07 M(-70.0%) | -$809.00 K(-100.4%) |
| June 2024 | - | $76.84 M(-325.1%) | $218.45 M(+407.8%) |
| Mar 2024 | - | -$34.14 M(-48.7%) | $43.02 M(+834.4%) |
| Dec 2023 | $4.60 M(-96.0%) | -$66.58 M(-127.5%) | $4.60 M(-97.0%) |
| Sept 2023 | - | $242.32 M(-345.8%) | $151.58 M(-511.5%) |
| June 2023 | - | -$98.59 M(+35.9%) | -$36.83 M(-2593.8%) |
| Mar 2023 | - | -$72.55 M(-190.2%) | $1.48 M(-98.7%) |
| Dec 2022 | $116.08 M(-117.1%) | $80.40 M(+49.1%) | $116.08 M(+14.4%) |
| Sept 2022 | - | $53.91 M(-189.4%) | $101.43 M(-141.6%) |
| June 2022 | - | -$60.28 M(-243.3%) | -$244.12 M(-62.1%) |
| Mar 2022 | - | $42.05 M(-36.0%) | -$644.65 M(-5.0%) |
| Dec 2021 | -$678.53 M(+209.4%) | $65.75 M(-122.5%) | -$678.53 M(-19.5%) |
| Sept 2021 | - | -$291.65 M(-36.7%) | -$842.78 M(+37.1%) |
| June 2021 | - | -$460.81 M(-5740.2%) | -$614.77 M(+292.0%) |
| Mar 2021 | - | $8.17 M(-108.3%) | -$156.82 M(-28.5%) |
| Dec 2020 | -$219.32 M(-453.5%) | -$98.50 M(+54.8%) | -$219.32 M(+76.5%) |
| Sept 2020 | - | -$63.64 M(+2126.0%) | -$124.23 M(+203.5%) |
| June 2020 | - | -$2.86 M(-94.7%) | -$40.94 M(+35.3%) |
| Mar 2020 | - | -$54.33 M(+1494.1%) | -$30.26 M(-148.8%) |
| Dec 2019 | $62.05 M(-261.5%) | -$3.41 M(-117.3%) | $62.05 M(+3.5%) |
| Sept 2019 | - | $19.66 M(+151.7%) | $59.94 M(+1939.5%) |
| June 2019 | - | $7.81 M(-79.4%) | $2.94 M(-59.8%) |
| Mar 2019 | - | $37.98 M(-789.0%) | $7.32 M(-119.0%) |
| Dec 2018 | -$38.41 M(+2380.0%) | -$5.51 M(-85.2%) | -$38.41 M(+72.9%) |
| Sept 2018 | - | -$37.34 M(-406.3%) | -$22.22 M(-211.1%) |
| June 2018 | - | $12.19 M(-257.3%) | $20.00 M(-157.5%) |
| Mar 2018 | - | -$7.75 M(-172.6%) | -$34.78 M(+2145.2%) |
| Dec 2017 | -$1.55 M(-89.6%) | $10.68 M(+118.7%) | -$1.55 M(-72.1%) |
| Sept 2017 | - | $4.88 M(-111.5%) | -$5.56 M(-1407.5%) |
| June 2017 | - | -$42.59 M(-267.2%) | $425.00 K(-98.7%) |
| Mar 2017 | - | $25.48 M(+281.9%) | $33.86 M(-327.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$14.86 M(-272.7%) | $6.67 M(-38.6%) | -$14.86 M(-66.2%) |
| Sept 2016 | - | $10.87 M(-218.6%) | -$43.97 M(+9.2%) |
| June 2016 | - | -$9.16 M(-60.6%) | -$40.26 M(+34.5%) |
| Mar 2016 | - | -$23.24 M(+3.6%) | -$29.93 M(-447.8%) |
| Dec 2015 | $8.61 M(-56.0%) | -$22.43 M(-254.0%) | $8.61 M(-70.9%) |
| Sept 2015 | - | $14.57 M(+1145.0%) | $29.53 M(+6.8%) |
| June 2015 | - | $1.17 M(-92.4%) | $27.66 M(+3.7%) |
| Mar 2015 | - | $15.30 M(-1113.9%) | $26.66 M(+36.3%) |
| Dec 2014 | $19.56 M(-159.1%) | -$1.51 M(-111.9%) | $19.56 M(-735.4%) |
| Sept 2014 | - | $12.70 M(+6992.7%) | -$3.08 M(-74.4%) |
| June 2014 | - | $179.00 K(-97.8%) | -$12.01 M(-37.9%) |
| Mar 2014 | - | $8.20 M(-133.9%) | -$19.34 M(-41.6%) |
| Dec 2013 | -$33.12 M(-153.6%) | -$24.15 M(-741.8%) | -$33.12 M(-242.5%) |
| Sept 2013 | - | $3.76 M(-152.7%) | $23.24 M(-34.3%) |
| June 2013 | - | -$7.14 M(+28.0%) | $35.38 M(-18.2%) |
| Mar 2013 | - | -$5.58 M(-117.3%) | $43.23 M(-30.0%) |
| Dec 2012 | $61.79 M(+858.6%) | $32.20 M(+102.5%) | $61.79 M(+36.1%) |
| Sept 2012 | - | $15.90 M(+2139.6%) | $45.39 M(-13.7%) |
| June 2012 | - | $710.00 K(-94.5%) | $52.57 M(+6.6%) |
| Mar 2012 | - | $12.98 M(-17.9%) | $49.33 M(+665.3%) |
| Dec 2011 | $6.45 M(-104.7%) | $15.80 M(-31.5%) | $6.45 M(-106.7%) |
| Sept 2011 | - | $23.08 M(-1013.8%) | -$96.87 M(-20.9%) |
| June 2011 | - | -$2.53 M(-91.6%) | -$122.46 M(-28.2%) |
| Mar 2011 | - | -$29.91 M(-65.8%) | -$170.47 M(+23.3%) |
| Dec 2010 | -$138.25 M(-843.5%) | -$87.51 M(+3385.1%) | -$138.25 M(+172.5%) |
| Sept 2010 | - | -$2.51 M(-95.0%) | -$50.74 M(+5.2%) |
| June 2010 | - | -$50.53 M(-2290.5%) | -$48.23 M(-2190.5%) |
| Mar 2010 | - | $2.31 M | $2.31 M |
| Dec 2009 | $18.59 M(-278.9%) | - | - |
| Dec 2008 | -$10.39 M(-43.3%) | - | - |
| Dec 2007 | -$18.34 M | - | - |
FAQ
- What is Pacific Biosciences of California annual cash flow from investing activities?
- What is the all time high annual CFI for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual CFI year-on-year change?
- What is Pacific Biosciences of California quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly CFI year-on-year change?
- What is Pacific Biosciences of California TTM cash flow from investing activities?
- What is the all time high TTM CFI for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM CFI year-on-year change?
What is Pacific Biosciences of California annual cash flow from investing activities?
The current annual CFI of PACB is $4.60 M
What is the all time high annual CFI for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual cash flow from investing activities is $116.08 M
What is Pacific Biosciences of California annual CFI year-on-year change?
Over the past year, PACB annual cash flow from investing activities has changed by -$111.48 M (-96.03%)
What is Pacific Biosciences of California quarterly cash flow from investing activities?
The current quarterly CFI of PACB is $23.07 M
What is the all time high quarterly CFI for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly cash flow from investing activities is $242.32 M
What is Pacific Biosciences of California quarterly CFI year-on-year change?
Over the past year, PACB quarterly cash flow from investing activities has changed by -$219.26 M (-90.48%)
What is Pacific Biosciences of California TTM cash flow from investing activities?
The current TTM CFI of PACB is -$809.00 K
What is the all time high TTM CFI for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM cash flow from investing activities is $218.45 M
What is Pacific Biosciences of California TTM CFI year-on-year change?
Over the past year, PACB TTM cash flow from investing activities has changed by -$152.39 M (-100.53%)